Associate Professor Ross Sharpe has over 25 years of clinical experience with specific qualifications in endovascular, coronary and structural cardiac interventions.

He studied a Bachelors of Medicine and Surgery at the University of Queensland and since then has remained passionately committed to using new and improved cardiac techniques and procedures. As such, he was the first cardiologist in Australia to be trained in Endovascular interventions, as recognised by the Colleges of Physicians, Surgeons and Radiologists. He is an international proctor for left atrial appendage closure.

A/Prof Ross Sharpe has a special interest in the treatment of structural and congenital heart disease and has expertise in PFO, LAA and ASD closures having performed over 700 of these procedures.

A/Prof Sharpe regularly trains junior cardiologists in new interventional techniques and also partakes in live conference case demonstrations. Particularly of note, he introduced one of the first Acute Myocardial Infarct Interventional Services in Australia to the Allamanda Private Hospital in 1999.

A/Prof Sharpe’s research concentrates largely on the impact that cardiovascular disorders have on neurological function and disease. He chairs the PFO Research Foundation, an international research consortium that focuses on investigating “omic” variances in Patent Foramen Ovale diseases including stroke and migraine.

Amongst his clinical practice and research engagements, he also sits on various US Medical Device Company Advisory Boards and is Adjunct Associate Professor, Faculty of Health Sciences and Medicine at Bond University, Gold Coast